Inage Y, Ogata T, Yamamoto T, Akaogi E, Horiguchi H, Kamma H, Satoh Y, Ishikawa S, Onizuka M, Sakakibara Y
Department of Thoracic Surgery, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Lung Cancer. 2001 Dec;34(3):351-61. doi: 10.1016/s0169-5002(01)00262-8.
The significance of p53 mutations and DNA aneuploidy in carcinoma cells has been investigated on the basis of a multi-step development theory of carcinogenesis. It has, however, not been determined whether these alterations can be used as diagnostic markers for the early detection of bronchial squamous cell carcinoma (BSqCC). To address this problem, we topographically investigated p53 alterations and DNA aneuploidy in 24 X-ray-negative, early BSqCC patients with various preneoplastic lesions and in 25 non-carcinoma patients with preneoplastic lesions. Bronchial lesions (n=88) were morphologically classified as hyperplasia (HP, n=5), squamous metaplasia (SM, n=23), low-grade dysplasia (LGD, n=14), high-grade dysplasia (HGD, n=11), intraepithelial carcinoma including 'carcinoma in situ' (CIS) (IEC, n=15), and microinvasive carcinoma (MIC, n=20). Immunohistochemistry for the p53 protein and image cytometry for DNA ploidy detection were performed in serial sections of each lesion. Overexpression of p53 protein was detected in 36, 73, and 65% of the HGD, IEC, and MIC lesions, respectively. Aneuploid DNA profiles were found only in carcinoma lesions, 33% in IEC and 85% in MIC. The topographical analysis revealed two types of early BSqCCs, one with adjacent preneoplastic lesions (sequential type, n=8) and another without such lesions (de novo type, n=16). The p53 protein was frequently overexpressed in both types (sequential type, 79%; de novo type, 62%). In the sequential type, however, the p53 protein was overexpressed in HGD lesions that were directly adjacent to p53-overexpressing carcinoma lesions without exception. The present topographical study suggests that p53 mutations play an important role in the carcinogenesis of BSqCC and that p53-overexpressing HGD lesions in sequential types should be regarded as 'truly' preneoplastic lesions that actually develop into carcinomas. In addition, our study demonstrated that DNA aneuploidy might occur at times after p53 alteration with increasing frequency, as invasive growth begins. Such combination analysis of p53 immunohistochemistry and nuclear DNA ploidy in routine histology may contribute to estimates of malignant potential in preneoplastic and intraepithelial squamous lesions and provide additional information for early detection of BSqCC.
基于肿瘤发生的多步骤发展理论,对癌细胞中p53突变和DNA非整倍体的意义进行了研究。然而,尚未确定这些改变是否可作为支气管鳞状细胞癌(BSqCC)早期检测的诊断标志物。为了解决这个问题,我们对24例X线阴性、患有各种癌前病变的早期BSqCC患者以及25例患有癌前病变的非癌患者进行了p53改变和DNA非整倍体的局部分析。支气管病变(n = 88)在形态学上分为增生(HP,n = 5)、鳞状化生(SM,n = 23)、低级别发育异常(LGD,n = 14)、高级别发育异常(HGD,n = 11)、包括“原位癌”(CIS)的上皮内癌(IEC,n = 15)和微浸润癌(MIC,n = 20)。对每个病变的连续切片进行p53蛋白免疫组织化学和DNA倍性检测的图像细胞术分析。分别在36%、73%和65%的HGD、IEC和MIC病变中检测到p53蛋白过表达。仅在癌病变中发现非整倍体DNA图谱,IEC中为33%,MIC中为85%。局部分析显示早期BSqCC有两种类型,一种伴有相邻癌前病变(连续型,n = 8),另一种无此类病变(新发型,n = 16)。两种类型中p53蛋白均经常过表达(连续型,79%;新发型,62%)。然而,在连续型中,p53蛋白无一例外在与p53过表达癌病变直接相邻的HGD病变中过表达。目前的局部研究表明,p53突变在BSqCC的致癌过程中起重要作用,连续型中p53过表达的HGD病变应被视为实际发展为癌的“真正”癌前病变。此外,我们的研究表明,随着侵袭性生长开始,DNA非整倍体可能在p53改变后有时出现且频率增加。在常规组织学中对p53免疫组织化学和核DNA倍性进行这种联合分析可能有助于评估癌前和上皮内鳞状病变的恶性潜能,并为BSqCC的早期检测提供额外信息。